Robert Michael Floyd serves as Executive at Processa Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert Michael Floyd has executed 8 insider transactions totaling $14.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 9, 2023 involved receiving (via award) 10,000 shares valued at $8.0K.
Robert Michael Floyd currently holds 82,267 shares of Processa Pharmaceuticals, Inc. (PCSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Michael Floyd has been a net buyer of PCSA stock. They have purchased $14.1K and sold $0 worth of shares.
Robert Michael Floyd's most recent insider trade was on Feb 9, 2023, when they sold 10,000 shares at $0.80 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 6, 2022 | PCSA | $0 | Payment | 4,163 | $N/A | Discretionary |
| Aug 16, 2022 | PCSA | $0 | Gift | 7,000 | $N/A | Discretionary |
| Mar 31, 2022 | PCSA | $0 | Gift | 7,000 | $N/A | Discretionary |
| Oct 6, 2021 | PCSA | $0 | Option Exercise | 12,500 | $N/A | Discretionary |
| Oct 6, 2021 | PCSA | $0 | Payment | 4,663 | $N/A | Discretionary |
| Jun 22, 2021 | PCSA | $14.1K | Purchase | 2,000 | $7.03 | Discretionary |